BridgeMD
Prevention study for Post-stroke Depression
Official title Behavioral Activation for the PreVention of Post-strokE Depression in LoW-incomE Older Stroke Survivors
ClinicalTrials.gov ID: NCT06864715
What this study is testing
- What it's testing
- The overall objective of the project is to determine the effectiveness of tele-delivered behavioral activation (BA) by trained lay counselors (Tele-BA-S) to prevent Post-stroke depression (PSD) in low-income, older stroke survivors with subthreshold depression (SD).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older
You may be able to join if
- Enrollment within 3-months +2 weeks of a first-time ischemic or hemorrhagic stroke
- 24-item HDRS score \< 15 indicating subthreshold depression defined as the absence of depressive symptoms or presence of mild symptoms of depression
- Single person income less than or equal to $45,000
- Residing in a community residence
- Ability to speak and read in English or Spanish
You likely can't join if
- Stroke event unrelated to vascular risk factors (e.g., drug use) or transient ischemic attack
- 24-item HDRS score \> or equal to 15 indicating moderate to severe depression
- Actively participating in psychotherapy
- high suicide risk or severe psychiatric illness (e.g., bipolar disorder and active psychosis) and/or actively taking antipsychotics
- Diagnosed dementia and/or currently taking cognitive enhancers, amyloid-targeting medications, or orexin receptor antagonists
- Patient Health Questionnaire 9 score \> or equal to 10 and/or answers positive to Q9
See the full eligibility criteria
- Enrollment within 3-months +2 weeks of a first-time ischemic or hemorrhagic stroke
- 24-item HDRS score \< 15 indicating subthreshold depression defined as the absence of depressive symptoms or presence of mild symptoms of depression
- Single person income less than or equal to $45,000
- Residing in a community residence
- Ability to speak and read in English or Spanish
- Mini-MoCA score \> or equal to 11
- Stroke event unrelated to vascular risk factors (e.g., drug use) or transient ischemic attack
- 24-item HDRS score \> or equal to 15 indicating moderate to severe depression
- Actively participating in psychotherapy
- high suicide risk or severe psychiatric illness (e.g., bipolar disorder and active psychosis) and/or actively taking antipsychotics
- Diagnosed dementia and/or currently taking cognitive enhancers, amyloid-targeting medications, or orexin receptor antagonists
- Patient Health Questionnaire 9 score \> or equal to 10 and/or answers positive to Q9
- Diagnosed aphasia and/or severe cognitive impairments
- high-risk alcohol or drug misuse
- receiving medications for mood disorders and a change in dose or type within the last 4 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.